SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-20-003923
Filing Date
2020-04-15
Accepted
2020-04-15 16:28:05
Documents
3
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20200415xdefa14a.htm DEFA14A 40799
2 GRAPHIC tmb-20200415xdefa14ag001.gif GRAPHIC 125117
3 GRAPHIC tmb-20200415xdefa14ag002.gif GRAPHIC 70418
  Complete submission text file 0001558370-20-003923.txt   311306
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 20794000
SIC: 2834 Pharmaceutical Preparations